BioNTech SE (BNTX) EBIT Margin Growth (3y) (2021 - 2025)
BioNTech SE (BNTX) EBIT Margin Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn | -11,254.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11,254.00 |
| Sep 30, 2025 | -9,529.00 |
| Jun 30, 2025 | -34,082.00 |
| Mar 31, 2025 | -37,778.00 |
| Dec 31, 2024 | -7,246.00 |
| Sep 30, 2024 | -7,675.00 |
| Jun 30, 2024 | -82,983.00 |
| Mar 31, 2024 | -35,151.00 |
| Dec 31, 2023 | 3,558.00 |
| Sep 30, 2023 | -26,798.00 |
| Jun 30, 2023 | -52,961.00 |
| Mar 31, 2023 | -16,283.00 |
| Sep 30, 2022 | -3,645.00 |
| Jun 30, 2022 | -3,695.00 |
| Mar 31, 2022 | -8,200.00 |
| Dec 31, 2021 | 8,486.00 |
| Sep 30, 2021 | 7,760.00 |